Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
06/13/2012 | CN102488867A Novel application of pharmaceutical composition |
06/13/2012 | CN102488865A Traditional Chinese medicine for fast healing of postoperative incision |
06/13/2012 | CN102488856A Externally applied traditional Chinese medicine composition for treating psoriasis |
06/13/2012 | CN102488852A Anti-acne composition and its preparation method |
06/13/2012 | CN102488823A Medicine for treating whelk and production method thereof |
06/13/2012 | CN102488795A Medicine for treating radiation dermatitis after head neck radiotheraphy |
06/13/2012 | CN102488791A Chinese traditional medicine granule for eczema and dermatitis |
06/13/2012 | CN102488763A Composition with functions of treating dysmenorrhoea and beautifying |
06/13/2012 | CN102488750A Xiasangju capsule and its preparation method |
06/13/2012 | CN102488739A Folk recipe foot bath composition |
06/13/2012 | CN102488738A Traditional Chinese medicine foot bath composition |
06/13/2012 | CN102488737A Traditional Chinese medicine composition for removing facial nevi |
06/13/2012 | CN102488736A Natural medicine foot bath composition |
06/13/2012 | CN102488720A Preparation method for submicron pine needle powder at normal temperature and special bidirectional air-flow screening machine |
06/13/2012 | CN102488716A 抗过敏剂 Antiallergic agent |
06/13/2012 | CN102488705A Skin mucous membrane disinfectant for killing virus |
06/13/2012 | CN102488685A Application method of liposome preparation containing compound amino acid component |
06/13/2012 | CN102488678A Application of embelin to preparation of medicament for treating autoimmune disease |
06/13/2012 | CN102487842A Mineral substance and Chinese herbal medicine nursing pad for pets |
06/13/2012 | CN102178876B Traditional Chinese medicine hip bath lotion for treating Anal eczema |
06/13/2012 | CN102138996B Honey pomelo peel processing powder |
06/13/2012 | CN102125647B Traditional Chinese medicine for treating alopecia |
06/13/2012 | CN101987125B Medicine for treating verruca plana and preparation method thereof |
06/13/2012 | CN101983693B Drug for treating alopecia and preparation method thereof |
06/13/2012 | CN101970639B Microorganism producing cyclic compound |
06/13/2012 | CN101875699B Fusion protein of human epidermal growth factor and metallothionein and preparation method and application thereof |
06/13/2012 | CN101869546B Supermolecular gel used for protecting photostability of vitamin A derivatives and its preparation method |
06/13/2012 | CN101810844B External plaster for preventing disease and manufacturing method thereof |
06/13/2012 | CN101732327B Cream liniment for treating infantile eczema |
06/13/2012 | CN101721556B Medicament composition with anti-inflammatory function and preparation method thereof |
06/13/2012 | CN101524462B Garlic volatile oil composition, preparation method of cream preparation thereof and application of cream preparation to treating microbial infection of skin and mucous membrane |
06/13/2012 | CN101343315B Shorten human papilloma virus 6 type L1 protein |
06/12/2012 | US8198483 Phenethanolamine derivatives for treatment of respiratory diseases |
06/12/2012 | US8198323 Curcumin analogues and uses thereof |
06/12/2012 | US8198295 Benzonaphthyridines |
06/12/2012 | US8198288 Tetrahydropyrrolopyrimidinediones and their use in therapy |
06/12/2012 | US8198286 Sodium channel blockers |
06/12/2012 | US8197843 Device for the administration of an active agent to the human skin |
06/12/2012 | US8197838 Sustained release systems of ascorbic acid phosphate |
06/12/2012 | US8197814 Method for treating the Th2-mediated disease |
06/12/2012 | US8197813 Human antibodies that bind human TNFα |
06/12/2012 | CA2437321C Vapor fraction from seeds of glycine max (l.) merr. and composition thereof |
06/07/2012 | WO2012075174A2 Compounds and methods for skin repair |
06/07/2012 | WO2012074926A1 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
06/07/2012 | WO2012074187A1 Pharmaceutical composition for preventing or treating autophagy-related diseases, angiogenic diseases or melanin-related diseases |
06/07/2012 | WO2012074068A1 Method for producing hematopoietic stem cells using pyrazole compound |
06/07/2012 | WO2012074037A1 Breast enhancement accelerator |
06/07/2012 | WO2012073184A1 Quinolin-4 (1h) -one derivatives as inhibitors of phosphatidylinositol 3-kinases |
06/07/2012 | WO2012071654A1 Treatment and prevention of eczema |
06/07/2012 | WO2012071648A1 Egfr antagonist for the treatment of heart disease |
06/07/2012 | WO2012037912A3 Use of corrinoids for pharmaceutical application in the event of coat and skin disorders in small and large animals (warm- and cold-blooded) {for example in fish, birds, horses, cattle, camels, dogs, cats, reptiles} |
06/07/2012 | WO2012026766A3 Novel heterocyclic compound, and composition for treating inflammatory diseases using same |
06/07/2012 | WO2012026765A3 Novel heterocyclic compound, and composition for treating inflammatory diseases using same |
06/07/2012 | WO2012010120A3 Use of corrinoids for cosmetic application in the case of healthy coats and/or healthy skin, and for cosmetic care in the case of coat and skin illnesses for small and large animals (warm- and cold-blooded) {for example, for fish, birds, horses, cows, camels, dogs, cats, reptiles} |
06/07/2012 | WO2011142588A9 Method for preparing autologous skin cell agent for alleviating or treating skin defects |
06/07/2012 | US20120144504 Caspase-8 and skin disease |
06/07/2012 | US20120142941 Composition for alleviating ultraviolet radiation-induced damage |
06/07/2012 | US20120142780 Use of 2,5-dihydroxybenzenesulfonic acid in the manufacturing of medicines, applicable to the treatment of angiodependent diseases |
06/07/2012 | US20120142773 Use of pufas for treating skin inflammation |
06/07/2012 | US20120142755 Compositions for preventing, reducing or treating keratinocyte-mediated inflammation |
06/07/2012 | US20120142748 Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation |
06/07/2012 | US20120142745 Novel phenyl oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
06/07/2012 | US20120142744 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
06/07/2012 | US20120142740 Novel alkene derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
06/07/2012 | US20120142739 Novel oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
06/07/2012 | US20120142738 Pharmaceutical composition for treating dermatological autoimmune diseases |
06/07/2012 | US20120142736 Novel pyridine derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
06/07/2012 | US20120142735 Disubstituted [4-(5-aminomethyl-phenyl)-piperidin-1-yl]- 1h-indol-3-yl]-methanones |
06/07/2012 | US20120142733 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of ccr2 |
06/07/2012 | US20120142726 Pharmaceutical compositions comprising 3,4-dihydroisoquinolin-2(1h)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity |
06/07/2012 | US20120142692 Antifolate combinations |
06/07/2012 | US20120142684 Compounds and methods for skin repair |
06/07/2012 | US20120142683 Pyrimidine substituted purine compounds as kinase (s) inhibitors |
06/07/2012 | US20120142677 Pyrrolidine Compounds Which Modulate The CB2 Receptor |
06/07/2012 | US20120142671 Benzamides and nicotinamides as syk modulators |
06/07/2012 | US20120142670 N-(amino-heteroaryl)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy |
06/07/2012 | US20120142669 N-(amino-heteroaryl)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy |
06/07/2012 | US20120142666 Azetidine 2-Carboxamide Derivatives Which Modulate The CB2 Receptor |
06/07/2012 | US20120142664 Novel benzyl azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
06/07/2012 | US20120142663 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
06/07/2012 | US20120142662 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
06/07/2012 | US20120142661 Novel oxime azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
06/07/2012 | US20120142642 Novel oxime derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
06/07/2012 | US20120142640 Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators |
06/07/2012 | US20120142639 Oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
06/07/2012 | US20120142637 Prodrugs of 6-cyclohexyl-1-hydroxy-4-methylpyridin-2-(1h)- one and derivatives thereof |
06/07/2012 | US20120142636 Novel glucokinase activators and methods of using same |
06/07/2012 | US20120142631 Medicinal antidiaper rash cream incorporating a biopolymer and a process to make it |
06/07/2012 | US20120142620 Core 2 glcnac-t inhibitors |
06/07/2012 | US20120142605 Methods of treating psoriasis |
06/07/2012 | US20120142598 Edible compositions for preventing hair loss |
06/07/2012 | US20120142595 Tissue protective peptides and uses thereof |
06/07/2012 | US20120141615 Method for suppressing and relieving itching and inflammation |
06/07/2012 | US20120141613 Composition containing a natural extract |
06/07/2012 | US20120141595 Umbilical cord amniotic membrane products |
06/07/2012 | US20120141576 Treatment of Dermatologic Skin Disorders |
06/07/2012 | US20120141575 Collagen For Use In The Treatment Of Skin Diseases |
06/07/2012 | US20120141565 Glycerosomes and use thereof in pharmaceutical and cosmetic preparations for topical applications |
06/07/2012 | US20120141559 Bio-membrane for tissue regeneration |
06/07/2012 | US20120141558 Alginate-based nanofibers and related scaffolds |